ClinicalTrials.gov
ClinicalTrials.gov Menu

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01784497
Recruitment Status : Completed
First Posted : February 6, 2013
Last Update Posted : October 15, 2014
Sponsor:
Information provided by (Responsible Party):
Iman Fawzy Montasser, Ain Shams University

Brief Summary:
Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Condition or disease
Health Related Quality of Life

Detailed Description:

This Study Aims to Evaluate:-

  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.
  2. Impact of post transplant medical and psychiatric complications on quality of life

Study Type : Observational
Actual Enrollment : 35 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2013
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
Recipients of Living Donor Liver Transplantation
Patients who will undergo Living Donor Liver Transplantation (LDLT) In Ain Shams Center For Organ Transplantation (ASCOT) .



Primary Outcome Measures :
  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score. [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Impact of post transplant medical and psychiatric complications on quality of life [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients who will undergo LDLT In Ain Shams Center For Organ Transplantation (ASCOT) in the next 6 months.
Criteria

Inclusion Criteria:

  • Adult Egyptian patients
  • 18-60 years old
  • Patients transplanted for HCV related disease and /or HCC
  • Informed consent

Exclusion Criteria:

  • Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01784497


Locations
Egypt
Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university
Cairo, Egypt
Sponsors and Collaborators
Ain Shams University

Responsible Party: Iman Fawzy Montasser, Lecturer of tropical medicine , Ain Shams university, Ain Shams University
ClinicalTrials.gov Identifier: NCT01784497     History of Changes
Other Study ID Numbers: PostTransplant Quality of life
First Posted: February 6, 2013    Key Record Dates
Last Update Posted: October 15, 2014
Last Verified: October 2014

Keywords provided by Iman Fawzy Montasser, Ain Shams University:
Health Related Quality of Life (HRQL)
Living Donor Liver Transplantation(LDLT)